{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:42:00Z","timestamp":1790041320516,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2016YFC1303503"],"award-info":[{"award-number":["2016YFC1303503"]}]},{"name":"the Key Biomedical Program of Shanghai","award":["17431902200"],"award-info":[{"award-number":["17431902200"]}]},{"name":"the Key Biomedical Program of Shanghai","award":["18431902600"],"award-info":[{"award-number":["18431902600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1083-5","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T10:04:16Z","timestamp":1550484256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma"],"prefix":"10.1186","volume":"38","author":[{"given":"Dan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-922X","authenticated-orcid":false,"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"1083_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","volume":"81","author":"JR Moffett","year":"2003","unstructured":"Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81:247\u201365.","journal-title":"Immunol Cell Biol"},{"key":"1083_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4137\/IJTR.S38355","volume":"9","author":"JP Routy","year":"2016","unstructured":"Routy JP, Routy B, Graziani GM, Mehraj V. The kynurenine pathway is a double-edged sword in immune-privileged sites and in Cancer: implications for immunotherapy. Int J Tryptophan Res. 2016;9:67\u201377.","journal-title":"Int J Tryptophan Res"},{"key":"1083_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","volume":"63","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Smith C, Thomas S, Mandik-Nayak L, Laury-Kleintop L, Metz R, et al. Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol Immun. 2014;63:721\u201335.","journal-title":"Cancer Immunol Immun"},{"key":"1083_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2016.02.024","volume":"6","author":"RB Holmgaard","year":"2016","unstructured":"Holmgaard RB, Zamarin D, Lesokhin A, Merghoub T, Wolchok JD. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors. Ebiomedicine. 2016;6:50\u20138.","journal-title":"Ebiomedicine"},{"key":"1083_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature13323","volume":"511","author":"A Bessede","year":"2014","unstructured":"Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 2014;511:184\u201390.","journal-title":"Nature"},{"key":"1083_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-12-39","volume":"12","author":"RPYA Bunaciu","year":"2013","unstructured":"Bunaciu RPYA. 6-Formylindolo (3, 2-b) carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Mol Cancer. 2013;12:1\u201311.","journal-title":"Mol Cancer"},{"key":"1083_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","volume":"115","author":"BC DiNatale","year":"2010","unstructured":"DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci. 2010;115:89\u201397.","journal-title":"Toxicol Sci"},{"key":"1083_CR8","doi-asserted-by":"crossref","unstructured":"Qian S, Zhang M, Chen QL, He YY, Wang W, Wang ZY. IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery. RSC Adv. 2016;6 61267\u201361267.","DOI":"10.1039\/C6RA90050J"},{"key":"1083_CR9","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1021\/jm401195n","volume":"56","author":"S Yang","year":"2013","unstructured":"Yang S, Li X, Hu F, Li Y, Yang Y, Yan J, et al. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. J Med Chem. 2013;56:8321\u201331.","journal-title":"J Med Chem"},{"key":"1083_CR10","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1021\/acs.jmedchem.5b00326","volume":"58","author":"UF Rohrig","year":"2015","unstructured":"Rohrig UF, Majjigapu SR, Vogel P, Zoete V, Michiein O. Challenges in the discovery of Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. J Med Chem. 2015;58:9421\u201337.","journal-title":"J Med Chem"},{"key":"1083_CR11","doi-asserted-by":"publisher","first-page":"973548","DOI":"10.1155\/2015\/973548","volume":"2015","author":"E Wirthgen","year":"2015","unstructured":"Wirthgen E, Hoeflich A. Endotoxin-induced tryptophan degradation along the kynurenine pathway: the role of indolamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immunosuppressive effects in endotoxin tolerance and cancer and its implications for immunoparalysis. J Amino Acids. 2015;2015:973548.","journal-title":"J Amino Acids"},{"key":"1083_CR12","first-page":"1","volume":"8","author":"EF Araujo de","year":"2017","unstructured":"de Araujo EF, Loures FV, Feriotti C, Costa T, Vacca C, Puccetti P, et al. Disease tolerance mediated by phosphorylated indoleamine-2,3 dioxygenase confers resistance to a primary fungal pathogen. Front Immunol. 2017;8:1\u201314.","journal-title":"Front Immunol"},{"key":"1083_CR13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1080\/09168451.2016.1274636","volume":"81","author":"M Koshiguchi","year":"2017","unstructured":"Koshiguchi M, Komazaki H, Hirai S, Egashira Y. Ferulic acid suppresses expression of tryptophan metabolic key enzyme indoleamine 2, 3-dioxygenase via NFkappaB and p38 MAPK in lipopolysaccharide-stimulated microglial cells. Biosci Biotechnol Biochem. 2017;81:966\u201371.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1083_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cyto.2006.07.007","volume":"35","author":"CM Robinson","year":"2006","unstructured":"Robinson CM, Hale PT, Carlin JM. NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha. Cytokine. 2006;35:53\u201361.","journal-title":"Cytokine"},{"key":"1083_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.18632\/oncotarget.1637","volume":"5","author":"UM Litzenburger","year":"2014","unstructured":"Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, et al. Constitutive IDO1 expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AhR. Oncotarget. 2014;5:1038\u201351.","journal-title":"Oncotarget"},{"key":"1083_CR16","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1128\/IAI.72.5.2723-2730.2004","volume":"72","author":"C Hucke","year":"2004","unstructured":"Hucke C, MacKenzie CR, Adjogble KDZ, Takikawa O, Daubener W. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun. 2004;72:2723\u201330.","journal-title":"Infect Immun"},{"key":"1083_CR17","doi-asserted-by":"publisher","first-page":"23778","DOI":"10.1074\/jbc.M700669200","volume":"282","author":"SR Thomas","year":"2007","unstructured":"Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, et al. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem. 2007;282:23778\u201387.","journal-title":"J Biol Chem"},{"key":"1083_CR18","doi-asserted-by":"crossref","unstructured":"Orabona C, Pallotta MT, Volpi C, Fallarino F, Vacca C, Bianchi R, et al. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proc Natl Acad Sci U S A 2008, 105: 20828\u201320833.","DOI":"10.1073\/pnas.0810278105"},{"key":"1083_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4137\/IJTR.S3971","volume":"3","author":"MT Pallotta","year":"2010","unstructured":"Pallotta MT, Orabona C, Volpi C, Grohmann U, Puccetti P, Fallarino F. Proteasomal degradation of indoleamine 2,3-dioxygenase in CD8 dendritic cells is mediated by suppressor of cytokine signaling 3 (SOCS3). Int J Tryptophan Res. 2010;3:91\u20137.","journal-title":"Int J Tryptophan Res"},{"key":"1083_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1162667","volume":"322","author":"G Yang","year":"2008","unstructured":"Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine \u03b3-lyase. Science. 2008;322:587\u201390.","journal-title":"Science"},{"key":"1083_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/pr.117.014050","volume":"69","author":"C Szabo","year":"2017","unstructured":"Szabo C, Papapetropoulos A. International Union of Basic and Clinical Pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors. Pharmacol Rev. 2017;69:497\u2013564.","journal-title":"Pharmacol Rev"},{"key":"1083_CR22","first-page":"re2","volume":"2","author":"AK Mustafa","year":"2009","unstructured":"Mustafa AK, Gadalla MM, Snyder SH. Signaling by gasotransmitters. Sci Signal. 2009;2:re2.","journal-title":"Sci Signal"},{"key":"1083_CR23","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1111\/bph.12773","volume":"171","author":"ZW Lee","year":"2014","unstructured":"Lee ZW, Teo XY, Tay EY, Tan CH, Hagen T, Moore PK, et al. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance. Brit J Pharmacol. 2014;171:4322\u201336.","journal-title":"Brit J Pharmacol"},{"key":"1083_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1096\/fj.12-216507","volume":"27","author":"K Modis","year":"2013","unstructured":"Modis K, Coletta C, Erdelyi K, Papapetropoulos A, Szabo C. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J. 2013;27:601\u201311.","journal-title":"FASEB J"},{"key":"1083_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1440-1681.2010.05371.x","volume":"37","author":"MJ Wang","year":"2010","unstructured":"Wang MJ, Cai WJ, Zhu YC. Mechanisms of angiogenesis: role of hydrogen sulphide. Clin Exp Pharmacol P. 2010;37:764\u201371.","journal-title":"Clin Exp Pharmacol P"},{"key":"1083_CR26","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","volume":"20","author":"RC Zanardo","year":"2006","unstructured":"Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006;20:2118\u201320.","journal-title":"FASEB J"},{"key":"1083_CR27","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1016\/j.bmcl.2009.09.030","volume":"19","author":"L Grossi","year":"2009","unstructured":"Grossi L. Hydrogen sulfide induces nitric oxide release from nitrite. Bioorg Med Chem Lett. 2009;19:6092\u20134.","journal-title":"Bioorg Med Chem Lett"},{"key":"1083_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bcp.2012.10.019","volume":"85","author":"K Kashfi","year":"2013","unstructured":"Kashfi K, Olson KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol. 2013;85:689\u2013703.","journal-title":"Biochem Pharmacol"},{"key":"1083_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbrc.2015.07.115","volume":"464","author":"B Huang","year":"2015","unstructured":"Huang B, Chen CT, Chen CS, Wang YM, Hsieh HJ, Wang DL. Laminar shear flow increases hydrogen sulfide and activates a nitric oxide producing signaling cascade in endothelial cells. Biochem Bioph Res Co. 2015;464:1254\u20139.","journal-title":"Biochem Bioph Res Co"},{"key":"1083_CR30","first-page":"1","volume":"2016","author":"N Li","year":"2016","unstructured":"Li N, Wang MJ, Jin S, Bai YD, Hou CL, Ma FF, et al. The H2S donor NaHS changes the expression pattern of H2S-producing enzymes after myocardial infarction. Oxidative Med Cell Longev. 2016;2016:1\u201311.","journal-title":"Oxidative Med Cell Longev"},{"key":"1083_CR31","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4014\/jmb.1709.09005","volume":"28","author":"C Monmai","year":"2018","unstructured":"Monmai C, Go SH, Shin IS, You S, Kim DO, Kang S, et al. Anti-inflammatory effect of Asterias amurensis fatty acids through NF-\u03baB and MAPK pathways against LPS-stimulated RAW264.7 cells. J Microbiol Biotechnol. 2018;28:1635\u201344.","journal-title":"J Microbiol Biotechnol"},{"key":"1083_CR32","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.4049\/jimmunol.1400833","volume":"193","author":"J Yu","year":"2014","unstructured":"Yu J, Wang Y, Yan F, Zhang P, Li H, Zhao H, et al. Noncanonical NF-kappaB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer. J Immunol. 2014;193:2574\u201386.","journal-title":"J Immunol"},{"key":"1083_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-016-0570-y","volume":"16","author":"A Al-Dhfyan","year":"2017","unstructured":"Al-Dhfyan A, Alhoshani A, Korashy HM. Aryl hydrocarbon receptor\/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and beta-catenin and Akt activation. Mol Cancer. 2017;16:14\u201332.","journal-title":"Mol Cancer"},{"key":"1083_CR34","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/carcin\/bgu067","volume":"35","author":"MG Borland","year":"2014","unstructured":"Borland MG, Krishnan P, Lee C, Albrecht PP, Shan W, Bility MT, et al. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) in keratinocytes. Carcinogenesis. 2014;35:1602\u201312.","journal-title":"Carcinogenesis"},{"key":"1083_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00051","volume":"8","author":"M El-Zaatari","year":"2017","unstructured":"El-Zaatari M, Kao JY. Role of dietary metabolites in regulating the host immune response in gastrointestinal disease. Front Immunol. 2017;8:1\u20139.","journal-title":"Front Immunol"},{"key":"1083_CR36","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.3390\/nu7105395","volume":"7","author":"W Li","year":"2015","unstructured":"Li W, Xu Q, He YF, Liu Y, Yang SB, Wang Z, et al. Anti-tumor effect of steamed Codonopsis lanceolata in H22 tumor-bearing mice and its possible mechanism. Nutrients. 2015;7:8294\u2013307.","journal-title":"Nutrients"},{"key":"1083_CR37","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","volume":"166","author":"DI Gabrilovich","year":"2001","unstructured":"Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature gr-1(+) myeloid cells. J Immunol. 2001;166:5398\u2013406.","journal-title":"J Immunol"},{"key":"1083_CR38","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111:4233\u201344.","journal-title":"Blood"},{"key":"1083_CR39","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","volume":"102","author":"C Melani","year":"2003","unstructured":"Melani C, Chiodoni C, Forni G, Colombo MP. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity. Blood. 2003;102:2138\u201345.","journal-title":"Blood"},{"key":"1083_CR40","first-page":"1","volume":"2018","author":"YX Jiang","year":"2018","unstructured":"Jiang YX, Dai YY, Pan YF, Wu XM, Yang Y, Bian K, et al. Total flavonoids from Radix Glycyrrhiza exert anti-inflammatory and Antitumorigenic effects by inactivating iNOS signaling pathways. Evid-Based Compl Alt. 2018;2018:1\u201310.","journal-title":"Evid-Based Compl Alt"},{"key":"1083_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cbi.2018.02.022","volume":"284","author":"SB Lee","year":"2018","unstructured":"Lee SB, Shin JS, Han HS, Lee HH, Park JC, Lee KT. Kaempferol 7- O - \u03b2 -D-glucoside isolated from the leaves of Cudrania tricuspidata inhibits LPS-induced expression of pro-inflammatory mediators through inactivation of NF-\u03baB, AP-1, and JAK-STAT in RAW 264.7 macrophages. Chem Biol Interact. 2018;284:101\u201311.","journal-title":"Chem Biol Interact"},{"key":"1083_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jri.2003.11.002","volume":"61","author":"A Honig","year":"2004","unstructured":"Honig A, Rieger L, Kapp M, Sutterlin M, Dietl J, Kammerer U. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. J Reprod Immunol. 2004;61:79\u201386.","journal-title":"J Reprod Immunol"},{"key":"1083_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1535-7163.MCT-09-0628","volume":"9","author":"HK Koblish","year":"2010","unstructured":"Koblish HK, Hansbury MJ, Bowman KJ, Yang GJ, Neilan CL, Haley PJ, et al. Hydroxyamidine inhibitors of Indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. Mol Cancer Ther. 2010;9:489\u201398.","journal-title":"Mol Cancer Ther"},{"key":"1083_CR44","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jaci.2015.10.033","volume":"137","author":"F Salazar","year":"2016","unstructured":"Salazar F, Hall L, Negm OH, Awuah D, Tighe PJ, Shakib F, et al. The mannose receptor negatively modulates the toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization. J Allergy Clin Immun. 2016;137:1841\u201351.","journal-title":"J Allergy Clin Immun"},{"key":"1083_CR45","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 1992;115:1249\u201373.","journal-title":"Brain"},{"key":"1083_CR46","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1016\/j.bmcl.2015.08.023","volume":"25","author":"F Vannini","year":"2015","unstructured":"Vannini F, MacKessack-Leitch AC, Eschbach EK, Chattopadhyay M, Kodela R, Kashfi K. Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid. Bioorg Med Chem Lett. 2015;25:4677\u201382.","journal-title":"Bioorg Med Chem Lett"},{"key":"1083_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3109\/08820139.2012.678023","volume":"41","author":"S Solito","year":"2012","unstructured":"Solito S, Pinton L, Damuzzo V, Mandruzzato S. Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. Immunol Investig. 2012;41:722\u201337.","journal-title":"Immunol Investig"},{"key":"1083_CR48","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2007.07.025","volume":"47","author":"M Zabala","year":"2007","unstructured":"Zabala M, Lasarte JJ, Perret C, Sola J, Berraondo P, Alfaro M, et al. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol. 2007;47:807\u201315.","journal-title":"J Hepatol"},{"key":"1083_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.26694","volume":"59","author":"Y Han","year":"2014","unstructured":"Han Y, Chen Z, Yang Y, Jiang Z, Gu Y, Liu Y, et al. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma. Hepatology. 2014;59:567\u201379.","journal-title":"Hepatology"},{"key":"1083_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1586\/ecp.10.122","volume":"4","author":"A Sparatore","year":"2011","unstructured":"Sparatore A, Santus G, Giustarini D, Rossi R, Del Soldato P. Therapeutic potential of new hydrogen sulfide-releasing hybrids. Expert Rev Clin Phar. 2011;4:109\u201321.","journal-title":"Expert Rev Clin Phar"},{"key":"1083_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JAD-2010-100684","volume":"22","author":"CJ Yu","year":"2010","unstructured":"Yu CJ, Zheng MF, Kuang CX, Huang WD, Yang Q. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro. J Alzheimers Dis. 2010;22:257\u201366.","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1083-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T10:38:42Z","timestamp":1582022322000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1083-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1083-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethics Committee of Fudan University and signed informed consent was obtained from each patient. All animal procedures were approved by the Animal Ethics Committee of Fudan University, experiments were performed in compliance with ARRIVE guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"88"}}